Chromogenic in situ HCR as a targeted translational interface for routine molecular histology.

Spatial transcriptomics has transformed tissue biology by preserving gene-expression information within intact histological architecture. However, its wider translational use remains limited by cost, platform complexity, computational burden, and uneven access to specialized infrastructure. The recent methodological framework by Yashiro et al. for chromogenic mRNA detection using in situ hybridization chain reaction (HCR) offers an opportunity to reconsider how selected molecular signals can be visualized in routine histological formats. This commentary has been reframed to position chromogenic in situ HCR not as a substitute for high-dimensional spatial transcriptomics, but as a targeted molecular histology approach that may validate or contextualize predefined transcripts identified through spatial discovery, conventional biology, or diagnostic hypotheses. Compared with conventional chromogenic in situ hybridization, the HCR strategy can improve signal amplification, reduce nonspecific background, and support more quantitative interpretation; compared with RNAscope, it may offer a potentially more accessible targeted RNA-detection route, although cost, probe synthesis, optimization, and reagent availability still require careful consideration. Its practical value is therefore strongest in narrow, marker-defined applications rather than in reconstruction of complex multigene spatial cell states. To realize this potential, the field should develop chromogenic HCR-specific reporting standards, benchmark performance across fixation conditions and tissue types, and clearly define infrastructure and validation requirements. Such an approach could strengthen targeted RNA histology while avoiding overstatement of clinical readiness or equivalence with spatial transcriptomics.